Elsevier

Hepatology

Volume 22, Issue 2, August 1995, Pages 505-513
Hepatology

Other clinical study
Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope

https://doi.org/10.1016/0270-9139(95)90572-3Get rights and content

Abstract

Primary biliary cirrhosis (PBC) is an autoimmune disease of liver associated with a unique serologic response to mitochondrial autoantigens. Many of the autoantigens recognized by autoantibodies in PBC are members of the 2-oxo-acid dehydrogenase complex. The two major autoantigens are the E2 component of the pyruvate dehydrogenase complex (PDC-E2) and the E2 component of the branched chain 2-oxo-acid dehydrogenase complex (BCOADC-E2). The autoantibody response to PDCE2 has been mapped to one immunodominant epitope, which consists of both linear and conformational components. The presence of a single immunodominant epitope in PDC-E2 is unusual when contrasted to the immune response to autoantigens in other human autoimmune diseases. We have mapped the epitope recognized by antimitochondrial autoantibodies (AMA) specific to BCOADC-E2 in patients with PBC by taking advantage of the full-length bovine BCOADC-E2 complementary DNA (cDNA) and a series of expression clones spanning the entire molecule. Reactivity to the various expression clones was studied by immunoblotting, enzyme-linked immunosorbent assay (ELISA), as well as selective absorption of patient sera by expressed protein fragments. Autoantibodies to BCOADC-E2 map within peptides spanning amino acid residues 1 to 227 of the mature protein; our data demonstrate that the epitope is dependent on conformation and includes the lipoic acid binding region. However, only the full-length clone (amino acid residue 1 to 421) is sufficient to remove all detectable BCOADC-E2 reactivity. Moreover, the absence of lipoic acid on the recombinant polypeptides used in this study indicates that antibody binding to BCOADC-E2 is not dependent on the presence of lipoic acid.

References (52)

  • OF James et al.

    Molecular aspects of the M2 autoantigens in primary biliary cirrhosis: What a difference a year makes

    Hepatology

    (1989)
  • IR Mackay et al.

    Primary biliary cirrhosis: considerations on pathogenesis based on identification of the M2 autoantigens

    Springer Semin Immunopathol

    (1990)
  • J Van de Water et al.

    Autoantibodies of primary biliary cirrhosis (PBC) recognize dihydrolipoamide acetyltransferase and inhibit enzyme function

    J Immunol

    (1988)
  • DR Fregeau et al.

    Antimitochondrial antibodies of primary biliary cirrhosis recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain a-keto acid dehydrogenase complex

    J Immunol

    (1989)
  • CD Surh et al.

    Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis

  • FH Pettit et al.

    Purification and characterization of branched chain a-keto acid dehydrogenase complex of bovine kidney

  • JJ Danner et al.

    Construction and nucleotide sequence of a cDNA encoding the full length preprotein for human branched chain acetyltransferase

    J Biol Chem

    (1989)
  • MS Patel et al.

    Molecular Biology and Biochemistry of pyruvate dehydrogenase complexes

    FASEB J

    (1990)
  • RN Perham

    Domains, motifs and linkers in 2-oxo-acid dehydrogenase multienzyme complex: a paradigm in the design of a multifunctional protein

    Biochemistry

    (1991)
  • F Sanger et al.

    DNA sequencing with chain terminating inhibitors

  • PSC Leung et al.

    Site-directed mutagenesis of lysine within the immunodominant autoepitope of PDC-E2

    Hepatology

    (1990)
  • ME Gershwin et al.

    Molecular cloning of the liver specific rat F antigen

    J Immunol

    (1987)
  • PE Pfeffer et al.

    α-anions of carboxylic acids. I. Effect of hexamethylphosphoramide on metalation and alkylation

    J Org Chem

    (1970)
  • PE Pfeffer et al.

    a-Anions of carboxylic acids. Ii. The formation and alkylation of a-methylated aliphatic acids

    J Org Chem

    (1972)
  • PE Pfeffer et al.

    a-Anions of carboxylic acids. V. A simple high yield presentation of a-alkylhydracrylic acids and a-alkylacrylic acids

    J Org Chem

    (1972)
  • DR Fregeau et al.

    Primary biliary cirrhosis

  • Cited by (107)

    • Primary biliary cholangitis

      2019, The Autoimmune Diseases
    • Transplantation for Primary Biliary Cirrhosis

      2015, Transplantation of the Liver: Third Edition
    • Environment and primary biliary cirrhosis: Electrophilic drugs and the induction of AMA

      2013, Journal of Autoimmunity
      Citation Excerpt :

      AMA is present in over 95% of patients with PBC and is the most specific diagnostic antibody marker of PBC [43]. The autoantigens of AMA have been identified as the E2 subunits of the 2-oxo-acid dehydrogenase complexes (2OADC-E2), including the E2 subunits of the pyruvate dehydrogenase complex (PDC-E2), branched chain 2-oxo acid dehydrogenase complex (BCOADC-E2) 2-oxo-glutarate dehydrogenase complex (OGDC-E2) [44–47] and the E3 binding protein of dihydrolipoamide dehydrogenase [48]. The AMA target antigens are all localized within the inner mitochondrial matrix and catalyze the oxidative decarboxylation of 2-oxo-acid acid substrates [49].

    • Xenobiotics and autoimmunity: Does acetaminophen cause primary biliary cirrhosis?

      2012, Trends in Molecular Medicine
      Citation Excerpt :

      AMAs are present in over 95% of patients with PBC and are the most specific diagnostic antibody marker of PBC [24,25]. The autoantigens of AMAs have been identified as the E2 subunits of the 2-oxo-acid dehydrogenase complexes (2OADC-E2), including the E2 subunits of the pyruvate dehydrogenase complex (PDC-E2), branched chain 2-oxo acid dehydrogenase complex (BCOADC-E2), and 2-oxo-glutarate dehydrogenase complex (OGDC-E2) [26–30]. The AMA target antigens are all localized to the inner mitochondrial matrix and catalyze the oxidative decarboxylation of 2-oxo-acid acid substrates [31].

    View all citing articles on Scopus

    This study was supported by NIH grants DK 39588 and AI 31585 and the Liver Tissue Procurement and Distribution System Grant 1-DK-6-2274.

    1

    Dr Cha's current address is the Department of Biology and Technology, Kangweon National University, Choonchan, South Korea.

    View full text